Date published:
Audience:
General public
Respiratory diseases, including lung cancer, impose a huge burden on health in Australia. But current diagnostic tools cannot provide the detailed assessment needed for early detection and diagnosis.
The XV-Perfusion lung scanner is safe, fast and does not require a contrast dye. It could provide the highly detailed information medical professionals need to detect lung diseases at an earlier stage.
The MRFF’s Medical Research Commercialisation initiative will support MTPConnect to partner with small and medium enterprises to commercialise this and 5 other life-saving devices.
Read the media release for more information.
Learn more about the MRFF.